Pharmaceutical & Life Sciences

Search Pharmaceutical & Life Sciences stories

Latest Stories

California School Dodges Some Title IX Claims Over Trans Athlete

A California school district avoided, for now, most Title IX claims brought by two cisgender female athletes who alleged a transgender student on their cross-country team is putting them at an unfair disadvantage.

By Mallory Culhane

Threat of Mass Job Cuts Raises Stakes of Government Shutdown

A fresh threat from President Donald Trump’s budget office of mass firings of federal workers if the government shuts down Oct. 1 incensed Democratic leaders and ramped up the political and economic stakes if lawmakers and the White House can’t reach a deal.

Army Hospital Wrongful Death Suit Has Potential Damages Limited

Only some of the plaintiffs in a wrongful death suit accusing a US Army hospital of negligence can sue, and they’re limited in the damages they can seek, a federal trial court said.

Stanford, Columbia Risk Getting Hit by Trump’s $100,000 H-1B Fee

President Donald Trump’s $100,000 fee for H-1B visas was a warning shot to Corporate America to toe the line on immigration. It also deals another financial blow to universities already battered by the administration’s crusade against top colleges.

Lee Memorial Hospital System Defeats Meta Pixel Use Class Action

Lee Memorial Health System is immune from a proposed class action over its use of Meta Platforms’ business tools, like the tracking pixel and the Conversions Application Programming Interface, a court ruled.

Eli Lilly Suit Over ‘Personalized’ Obesity Drugs Gets Go-Ahead

A federal judge allowed Eli Lilly & Co.‘s lawsuit alleging a drug compounder sold untested and unapproved versions of its obesity treatment to proceed while he also dismissed some of the drugmaker’s claims.

Health Insurers Target Consultant Over Surprise Billing Fraud

A string of lawsuits against a health-care consultant is spotlighting confusion around the arbitration process meant to stop surprise medical bills, as insurers allege providers are intentionally flooding the zone with ineligible claims.

Lilly Halts One Trial of Muscle-Sparing Drug With Zepbound

Eli Lilly & Co. halted a study of an experimental drug designed to prevent obesity patients from losing too much muscle, citing strategic business reasons it didn’t disclose.

WilmerHale Adds Pharma Legal Chief Andrea Paul in Boston Office

Andrea Paul is joining WilmerHale as a partner in its life sciences group in Boston, the firm announced Wednesday.

RFK Jr. Opens Investigation Into the Safety of the Abortion Pill

Health and Human Services Secretary Robert F. Kennedy Jr. opened an investigation into the safety of the abortion pill mifepristone, as the antiabortion movement continues to push the administration to restrict access through lawsuits and policy.